InMode (NASDAQ:INMD) is a health technology company, specialized in developing, manufacturing, and marketing devices that harness novel radio-frequency (RF) technology. These advanced devices are utilized in minimally invasive and non-invasive cosmetic and dermatological procedures, aiming to deliver innovative solutions that improve patient outcomes and enhance quality of life. The company has a diversified project portfolio, focusing on areas such as body contouring, aesthetic surgery, women’s health, and skin treatment. InMode's primary objective is to revolutionize the cosmetic surgery and dermatology sectors by providing safer, effective, and less invasive treatment options to patients worldwide. By leveraging cutting-edge RF technology, InMode seeks to lead transformations within these medical fields, ensuring professionals have access to the latest advancements in medical aesthetic treatments.